Skip to Content
Merck
All Photos(1)

Key Documents

G3295-4

Sigma-Aldrich

ProtaSea® Fucoidan

brown seaweed extract

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
12352201
NACRES:
NA.25

Quality Level

100

form

powder

pH

5.5-8.5 (20 °C, 1% in water)

viscosity

5-10 mPa.s

Application

NovaMatrix ProtaSea fucoidan is a brown seaweed extract from Laminaria Hyperborea. The product is manufactured in Norway from fresh seaweed sources, using natural extraction techniques. This allows ProtaSea fucoidans to be as close as possible to their natural state. Novamatrix ProtaSea fucoidan is 80% fucose. ProtaSea fucoidans can be used in personal care and nutraceutical products. ProtaSea fucoidans can potentially be used in drug therapy research, joint health, immune health, anti-inflammatory therapies, medical device coating, etc.

Legal Information

Product of Dupont Nutrition USA, Inc.
PROTASEA is a registered trademark of DuPont Nutrition USA, Inc.

Disclaimer

NOT FOR USE IN HUMANS

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service